Enalapril/hydrochlorothiazide

Enalapril/hydrochlorothiazide, sold under the brand name Vaseretic among others, is a combination drug used for the treatment of hypertension.[2] It contains enalapril and hydrochlorothiazide.[2] It is taken by mouth.[2]

Enalapril/hydrochlorothiazide
Combination of
EnalaprilACE inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
Trade namesVaseretic, others
AHFS/Drugs.comProfessional Drug Facts
MedlinePlusa601047
License data
Pregnancy
category
    Routes of
    administration    		By mouth
    ATC code
    Legal status
    Legal status
    • US: ℞-only
    • In general: ℞ (Prescription only)
    Identifiers
    UNII
    KEGG

    Enalapril is an angiotensin converting enzyme inhibitor and hydrochlorothiazide is a diuretic.

    The most frequent side effects are dizziness, headache, fatigue, and cough.[2]

    History

    Enalapril/hydrochlorothiazide was approved for use in the United States in October 1986.[3]

    References
    1. "Enalapril / hydrochlorothiazide (Vaseretic) Use During Pregnancy". Drugs.com. 29 May 2019. Retrieved 26 April 2020.
    2. "Enalapril Maleate and Hydrochlorothiazide- enalapril maleate and hydrochlorothiazide tablet". DailyMed. 29 January 2020. Retrieved 27 April 2020.
    3. "Vaseretic: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 26 April 2020.

    Further reading
    • Frishman WH, Goldberger J, Sherman D (December 1987). "Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension". J Clin Hypertens. 3 (4): 520–7. PMID 2839628.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.